What This Report
Will Provide?
This study involved four major
activities in estimating the current size of the home healthcare market.
Exhaustive secondary research was carried out to collect information on the
market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with
industry experts across the value chain through primary research. Both top-down
and bottom-up approaches were employed to estimate the complete market size.
After that, market breakdown and data triangulation procedures were used to
estimate the size of segments and subsegments.
Expected Revenue Growth:
[253 Pages Report] The global home
healthcare market size is projected to reach USD 274.7 billion by 2025 from
USD 181.9 billion in 2020, at a CAGR of 8.6%.
Major Growth Boosters:
Rapid growth in the elderly
population and the rising incidence of chronic diseases, growing need for
cost-effective healthcare delivery due to the increasing healthcare costs, and
technological advancements of home care devices.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=696
Recent Developments:
In 2019, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US).
This acquisition strengthens the company’s business in the US. It enables
Fresenius Medical Care to leverage it’s manufacturing, supply chain, and
marketing competencies across the dialysis products, services, and care
coordination businesses, especially in-home dialysis and critical care.
In 2020, Lincare, a subsidiary of Linde, offers home respiratory care in the US.
In response to the COVID-19 pandemic, the company offers in-home services to
COVID-19 vulnerable patients. It is also helping to ease the burden on
hospitals by transferring respiratory patients and others from in-patient to
in-home care.
LHC Group Inc (US) entered into a joint venture agreement with University
Health Care System (US). This joint venture agreement was aimed to strengthen
home health and hospice services across eight cities in Georgia and South
Carolina.
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global home healthcare
market?
2. What are the drivers, restraints, opportunities, and challenges in the home
healthcare Industry?
3. What are the opportunities for stakeholders and provide details of the
competitive landscape for key players?
4. What will be growth of home healthcare in North America, Europe, Asia
Pacific, Latin America, and the Middle East and Africa?
COVID-19 Impact on Home Healthcare Market:
The COVID-19 pandemic has a mixed impact on the
home healthcare industry. As the home healthcare market consists of products
and services, both have different effects. COVID-19 would positively impact few
home healthcare monitoring products such as blood glucose monitors, blood
pressure monitors, pulse oximeters, and temperature monitors.
Due to the coronavirus pandemic, one might be under the assumption that the
home healthcare service industry would be booming because home healthcare
providers would be able to treat the vulnerable and elderly population in the
comfort of their homes. However, the scenario is different. There have been
many home healthcare agencies and providers who have reported a decline in the
business. However, this downturn in the home healthcare industry is predicted
to be for a while, as the business will pick up at a faster pace in the coming
future as more people are recovering from COVID-19.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=696
Key Players in Home Healthcare Market:
The prominent players operating in this market include Fresenius SE &
Co. KGaA (Germany), GE Healthcare (US), Linde plc (Ireland), F. Hoffmann-La
Roche Ltd (Switzerland), Amedisys (US), Kindred at Home (US), and LHC Group,
Inc. (US)
